Clinical trials
Terminated Phase 1/2 Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aegera Therapeutics | 1 |
| Atara Biotherapeutics | 1 |
| Dana-Farber Cancer Institute | 1 |
| Elucida Oncology | 1 |
| Evopoint Biosciences Inc. | 1 |
| Generic Devices Consulting, Inc. | 1 |
| M.D. Anderson Cancer Center | 1 |
| NBE-Therapeutics AG | 1 |
| Numab Therapeutics AG | 1 |
| Rexahn Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 12 |
| Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Colorectal Neoplasms | 2 |
| Fallopian Tube Neoplasms | 2 |
| Head and Neck Neoplasms | 2 |
| Ovarian Neoplasms | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Carcinoma, Adenosquamous | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.